Second Medical Opinion

Your trusted source for evidence-based medical information, reviewed by healthcare professionals

✓ Medical Professional Reviewed ✓ Evidence-Based Content ✓ Regularly Updated

Fruzaqla / FRUQUINTINIB

Fruzaqla / FRUQUINTINIB

by

Description Fruzaqla is a medication used to treat metastatic colorectal cancer (mCRC) in adults. It contains the active ingredient Fruquintinib, which is a kinase inhibitor. Consult a doctor for personalized advice. Indications and Usage Fruzaqla is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have previously undergone fluoropyrimidine‑, oxaliplatin‑, and … Read more